Mode
Text Size
Log in / Sign up

Good antiretroviral therapy adherence is associated with a 6.30 odds ratio for viral load suppressionBetter adherence to HIV treatment links to lower viral loads

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the strong association between good ART adherence and viral load suppression in patients with HIV.

This meta-analysis synthesized data from 39 studies conducted in Ethiopia to evaluate the relationship between antiretroviral therapy (ART) adherence and viral load suppression among people living with HIV. The study aimed to quantify the prevalence of clinical outcomes and the strength of the association between patient adherence and treatment success.

The meta-analysis reported a pooled prevalence of 79.4% (95% CI: 74.8%-83.4%) for good ART adherence and a pooled prevalence of 77.5% (95% CI: 72.5%-81.8%) for viral load suppression. A positive association was identified between good ART adherence and viral load suppression, with a reported odds ratio of 6.30 (95% CI: 4.84-8.19).

Limitations noted by the authors include substantial heterogeneity (I2 > 90%) across the included studies. Because the underlying studies were observational, the results indicate an association rather than a confirmed causal link. These findings highlight adherence as a critical modifiable factor for achieving optimal treatment outcomes in HIV care.

How this fits prior evidence

This meta-analysis addresses a gap in quantifying the specific relationship between adherence and viral suppression in the Ethiopian context. It extends the evidence regarding the importance of behavioral interventions to improve ART adherence and viral suppression. While previous evidence confirmed that counseling and reminders improve adherence, this meta-analysis provides a specific odds ratio of 6.30 for the association between adherence and viral load suppression.

Living with HIV means managing a daily routine of medication to keep the virus in check. For many people, the biggest challenge is staying consistent with these pills. New data from a large review of 39 studies in Ethiopia highlights just how much this daily habit matters for long-term health.

The data shows that about 79.4% of people reported good adherence to their antiretroviral therapy. Among those who stayed consistent, the link to suppressing the virus was clear. Specifically, those with good adherence were over six times more likely to achieve a suppressed viral load compared to those who did not.

While the results show a strong connection between staying on track and better health outcomes, the study notes that the data came from various sources with different methods. This means while the link is strong, it shows an association rather than a direct cause. It highlights that sticking to the plan is a key factor for patients to reach their health goals.

What this means for you:
Consistent daily adherence to HIV medication is strongly linked to successfully lowering the amount of virus in the body.

Common questions

How does sticking to my medication help my health?

Staying consistent with antiretroviral therapy is a key factor for success. The study found that people with good adherence were over six times more likely to achieve a suppressed viral load, which means the amount of virus in their body stays low.

What did the study find about treatment success?

The review of 39 studies showed that 79.4% of people reported good adherence to their medication. Among those who stayed consistent, 77.5% achieved a suppressed viral load, showing a strong link between daily habits and treatment goals.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJan 2026
View Original Abstract ↓
BACKGROUND: Antiretroviral therapy (ART) adherence is a key determinant of viral load suppression among people living with HIV (PLHIV). In Ethiopia, evidence on the magnitude of ART adherence and its effect on virological outcomes remains fragmented. This systematic review and meta-analysis aimed to estimate the pooled prevalence of ART adherence and viral load suppression, and to measure the association between adherence and viral suppression among PLHIV in Ethiopia. METHODS: This systematic review and meta-analysis used the PRISMA checklist for systematic reviews and meta-analyses. The review protocol has been registered onPROSPERO:(CRD420251125899). PubMed, ScienceDirect, Scopus, Epistemonikos, and Google Scholar were searched. The quality of included articles has been evaluated with a Newcastle-Ottawa Scale (NOS), adapted for observational studies. A random-effects model using restricted maximum likelihood (REML) with Knapp-Hartung adjustment was used to estimate pooled prevalence and odds ratio. Heterogeneity was assessed using I2, τ2, and Cochran's Q test. RESULTS: A total of 39 studies were included in the final analysis. The pooled prevalence of good ART adherence was 79.4% (95% CI: 74.8%-83.4%), while the pooled viral load suppression rate was 77.5% (95% CI: 72.5%-81.8%). The pooled odds ratio showed that good ART adherence was strongly associated with viral load suppression (OR = 6.30, 95% CI: 4.84-8.19). Substantial heterogeneity was observed across studies for both adherence and viral suppression outcomes (I2 > 90%). CONCLUSIONS: ART adherence and viral load suppression among PLHIV in Ethiopia are relatively high but remain below global targets. Good adherence was significantly associated with virologic suppression, highlighting adherence as a critical modifiable factor for achieving optimal treatment outcomes. Strengthening adherence support interventions is essential to improve virological success and advance progress toward HIV epidemic control.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.